Living Cell Technologies (ASX:LCT)
Company Profile
Living Cell Technologies (ASX:LCT) has changed its name to Algorae Pharmaceuticals – 1AI (ASX: 1AI).
Below are the previous articles from Living Cell Technologies (ASX:LCT):
RELATED STOCKHEAD STORIES
Closing Bell: Catch up footy leaves benchmark nibbling at parity for second straight session
Algorae, UNSW work on ‘revolutionary’ AI platform to accelerate drug discovery and development
Market Highlights: Wall Street’s late selloff, home prices rebound, and 5 ASX small caps to watch today
ASX Health Stocks: Living Cells Tech files a patent for cannabis-based dementia drug
ASX Health Stocks: AVITA’s spray-on skin cells device RECELL pockets US FDA approval
CLOSING BELL: Shipments increase after China lifts the ban it never put on Aussie coal
As dementia takes toll on Aussies, here’s why Alterity and these ASX biotechs are in the box seat
Check Up: These 3 biotechs join the elite ASX 300 this week – and it could be a game-changer
Closing Bell: It’s trickle down economics… just not the kind you’re thinking of
Check Up: As the pandemic winds down, what’s happening with Covid focused biotechs?
ASX Health Stocks: Oneview extends software deal, LCT to start using AI technology
Market Highlights and 5 ASX Small Caps to watch on Monday
Check Up: More clinical trials and FDA funding boost. Is this the end of biotech’s woes?
